Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 26, 2019

Primary Completion Date

August 26, 2021

Study Completion Date

August 26, 2021

Conditions
HCC
Interventions
DIAGNOSTIC_TEST

Additional intraprocedural pre-ablation CT-scan

In 20 patients, besides de regular post-RFA scan, a pre-RFA contrast enhanced dual phase CT-scan will be acquired to investigate the feasibility of quantitative ablation assessment.

Trial Locations (1)

2333ZA

Leiden University Medical Center, Leiden

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Mirada Medical

UNKNOWN

lead

Leiden University Medical Center

OTHER

NCT04123340 - Intraprocedural Assessment of Ablation Margins Using Computed Tomography Co-registration in Primary Liver Tumor Treatment With Percutaneous Ablation | Biotech Hunter | Biotech Hunter